Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-26

Clinical Trial Update: Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial investigating botulinum toxin type A for chronic low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Ipsen | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED